ABSTRACT
Nanotechnology is being applied in medical sciences to try and create personalized medicine relying on biomarker-based proteomics and genomic technologies, while nanoparticles can be used for qualitative or quantitative in vivo or ex vivo diagnosis by concentrating, amplifying, and protecting a biomarker from degradation to provide a more sensitive analysis (Geho et al. 2004).
